“Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients With Type 2 Diabetes: Single-Blind Interventional Study With Placebo Control at Tertiary Care Setting Quetta”. Life and Science 6, no. 4 (October 8, 2025): 06. Accessed October 17, 2026. https://lifenscience.org/index.php/life-and-science/article/view/870.